Fortrea Holdings (FTRE) EBITDA Margin (2022 - 2026)
Fortrea Holdings' EBITDA Margin was 5.07% in Q2 2026, up 48.81 percentage points from -43.74% a year earlier and up 2.50 percentage points from the prior quarter.
Fortrea Holdings (FTRE) EBITDA Margin (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, Fortrea Holdings' EBITDA Margin was 2.52% through Jun 30, 2026, up 33.36 percentage points year-over-year; for FY2025, it was -29.18%, down 26.40 percentage points from FY2024.
- EBITDA Margin has now declined for three consecutive years, with a four-year change of -38.35 percentage points (FY2021 to FY2025).
- In earlier years, EBITDA Margin was -2.78% in FY2024 (-7.35 pp), 4.57% in FY2023 (-5.32 pp), 9.89% in FY2022 (+0.72 pp) and 9.18% in FY2021.
- The Q2 2026 figure marks the highest quarterly EBITDA Margin since Q2 2023.
- Compared with a year earlier, EBITDA Margin has increased for four straight quarters, with an average year-over-year change of +1.46 percentage points over the last eight quarters.
- The best year-over-year quarter for EBITDA Margin over five years was Q1 2026 (a gain of 79.44 percentage points); the worst was Q1 2025 (a drop of 74.76 percentage points).
- Per Business Quant data, FTRE's EBITDA Margin in the three quarters before Q2 2026 was 2.58% (Q1 2026), 0.86% (Q4 2025) and 1.57% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.55 Bn | 36.39 Bn | 1.44 Bn | 18.27% |
| 2 | Medpace Holdings | 17.19 Bn | 15.25 Bn | 201.64 Mn | 21.71% |
| 3 | Charles River Laboratories International | 14.06 Bn | 13.30 Bn | 363.37 Mn | 18.64% |
| 4 | Icon | 13.44 Bn | 10.55 Bn | 479.29 Mn | 11.15% |
| 5 | Fortrea Holdings | 1.91 Bn | 1.29 Bn | 139.20 Mn | 5.07% |
| 6 | Ginkgo Bioworks Holdings | 665.78 Mn | -96.30 Mn | 18.44 Mn | -229.38% |
| 7 | Evotec SE | 565.34 Mn | -1.01 Bn | - | - |
| 8 | Champions Oncology | 68.06 Mn | 43.71 Mn | 7.70 Mn | -0.62% |
| 9 | MindWalk Holdings | 62.59 Mn | 26.81 Mn | 1.61 Mn | -152.92% |
| 10 | Natural Alternatives International | 10.67 Mn | -22.35 Mn | 383,000.00 | -7.95% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.07% |
| Mar 31, 2026 | 2.58% |
| Dec 31, 2025 | 0.86% |
| Sep 30, 2025 | 1.57% |
| Jun 30, 2025 | -43.74% |
| Mar 31, 2025 | -76.86% |
| Dec 31, 2024 | -4.99% |
| Sep 30, 2024 | 0.47% |
| Jun 30, 2024 | -4.45% |
| Mar 31, 2024 | -2.10% |
| Dec 31, 2023 | 0.06% |
| Sep 30, 2023 | 4.89% |
| Jun 30, 2023 | 7.82% |
| Mar 31, 2023 | 5.36% |
| Dec 31, 2022 | 7.60% |
| Sep 30, 2022 | 12.02% |
| Jun 30, 2022 | 11.93% |
Fortrea Holdings EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=FTRE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "FTRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=FTRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();